The common antidepressant fluvoxamine significantly reduces fatigue and improves quality of life for patients suffering from long COVID.

WEDNESDAY, April 1, 2026 — A common antidepressant appears to help reduce fatigue in people living with long COVID, a new study...

WEDNESDAY, April 1, 2026 — A common antidepressant appears to help reduce fatigue in people living with long COVID, a new study says.Fluvoxamine...

FRIDAY, April 3, 2026 -- For patients with postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), fluvoxamine seems...

bRadiotherapy may significantly reduce the risk of medlinklymphedema/medlink (chronic arm swelling) in breast cancer patients/b compared to...

A common antidepressant could be the key to treating methamphetamine addiction, a landmark Australian research trial has found.

Burnout and chronic fatigue carry a substantial economic cost and pose serious risks in professions where alertness is critical.

Men with early-stage metastatic bmedlinkprostate cancer/medlink/b may soon be able to postpone the debilitating side effects of hormone therapy...

bSupplementing with medlinkprobiotics/medlink during the first trimester/b may be a breakthrough in breducing preterm birth/b and associated...

bSupplementing with medlinkprobiotics/medlink during the first trimester/b may be a breakthrough in breducing preterm birth/b and associated...